Devastating Impact on Patients and Medical Science from Government Price Controls
- Dec 11, 2023
- 1 min read
Updated: Dec 13, 2023
Government price controls will lead to sharp declines in U.S. clinical trial research for major public health issues like cancer, Alzheimer's, and obesity — threatening patient access to new medicines, according to a new U.S. Chamber study.